v3.26.1
Consolidated Statements of Comprehensive Income / (Loss) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Net sales $ 18,252 $ 10,981 $ 30,058
Cost of sales (9,116) (6,775) (15,589)
Depreciation of production assets (506) (478) (420)
Gross profit 8,630 3,728 14,049
Other operating income 2,607 359 48
Research & development expenses (12,477) (4,985) (3,946)
Selling & marketing expenses (12,768) (5,453) (5,648)
General & administrative expenses (25,791) (10,840) (8,644)
Total operating expenses (48,429) (20,919) (18,190)
Operating loss (39,799) (17,191) (4,141)
Non-operating income 8,897 1,061 2,442
Loss on debt extinguishment   (100)  
Interest and amortization of debt discount (223) (1,003) (689)
Non-operating expenses (3,083) (883) (655)
Loss before income tax expense (34,208) (18,116) (3,043)
Income tax (expense) / income 162 (3,085) (225)
Equity in earnings of unconsolidated affiliates (148)    
Net loss (34,194) (21,201) (3,268)
Other comprehensive income / (loss), net of tax:      
Foreign currency translation adjustments (39)   (2)
Unrealized holding gain arising during period 25    
Net gain / (loss) arising during period 108 (27) 11
Other comprehensive income / (loss) 94 (27) 9
Comprehensive loss $ (34,100) $ (21,228) $ (3,259)
Ordinary shares      
Earnings per F share (USD)      
Basic $ (0.24) $ (0.6) $ (0.21)
Diluted (0.24) (0.6) (0.21)
F shares      
Earnings per F share (USD)      
Basic (1.2) (3.01) (1.07)
Diluted $ (1.2) $ (3.01) $ (1.07)